MedPath

Artcline GmbH

🇩🇪Germany
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy - Observational Long-term Outcome Follow up

Recruiting
Conditions
Severe Sepsis
First Posted Date
2023-11-22
Last Posted Date
2024-08-02
Lead Sponsor
Artcline GmbH
Target Recruit Count
142
Registration Number
NCT06143137
Locations
🇩🇪

Klinikum Magdeburg, Klinik für Intensiv- und Rettungsmedizin, Magdeburg, Germany

🇩🇪

Universitätsmedizin Rostock, Abteilung KAI, Rostock, Germany

Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy

Phase 2
Recruiting
Conditions
Sepsis, Severe
Interventions
First Posted Date
2022-07-05
Last Posted Date
2025-05-25
Lead Sponsor
Artcline GmbH
Target Recruit Count
142
Registration Number
NCT05442710
Locations
🇩🇪

Universitätsklinikum Regensburg, Klinik für Anästhesiologie, Regensburg, Bayern, Germany

🇩🇪

Universitätsklinikum Bonn, Klinik und Poliklinik für Anästhesiologie und Operative Intensivmedizin, Bonn, Nordrhein-Westfalen, Germany

🇩🇪

Helios Klinikum Aue, Aue, Sachsen, Germany

and more 17 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.